SCHEMBL11389705

SCHEMBL11389705

CC(C)(C)CC(=O)C(=O)OBr

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8184932 0.77 TET2 (0.39)
SCHEMBL28667481 0.77 HMGCR (0.31)
SCHEMBL14914212 0.74 HMGCR (0.40)
SCHEMBL662694 0.74
SCHEMBL28331383 0.73 ALDH1A1 (0.41)
SCHEMBL4574752 0.73 ALDH1A1 (0.42)
SCHEMBL468417 0.70
SCHEMBL13995531 0.69 TRPA1 (0.38)
SCHEMBL3697055 0.67 HMGCR (0.41)
SCHEMBL6857048 0.67 CES1 (0.38)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 19 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12252511-B2 Process for the preparation of cyclic depsipeptides ONKURE, INC. (US) 2025-03-18 US disclosed
US-20240116989-A1 PROCESS FOR THE PREPARATION OF CYCLIC DEPSIPEPTIDES ONKURE, INC. (US) 2024-04-11 US disclosed
US-11739123-B2 Process for the preparation of cyclic depsipeptides ONKURE, INC. (US) 2023-08-29 US disclosed
CN-110156874-B Cyclic depsipeptide compounds 恩库勒公司 2023-04-18 CN disclosed
US-20220002347-A1 PROCESS FOR THE PREPARATION OF CYCLIC DEPSIPEPTIDES ONKURE, INC. (US) 2022-01-06 US disclosed
US-11053284-B2 Process for the preparation of cyclic depsipeptides ONKURE, INC. (US) 2021-07-06 US disclosed
EP-3578179-B1 PROCESS FOR THE PREPARATION OF CYCLIC DEPSIPEPTIDES ONKURE INC (US) 2020-12-23 EP disclosed
US-20200347097-A1 Process for the Preparation of Cyclic Depsipeptides ONKURE, INC. (US) 2020-11-05 US disclosed
US-10689419-B2 Process for the preparation of cyclic depsipeptides ONKURE, INC. (US) 2020-06-23 US disclosed
EP-3578179-A1 PROCESS FOR THE PREPARATION OF CYCLIC DEPSIPEPTIDES Onkure, Inc. (US) 2019-12-11 EP disclosed
US-20190177372-A1 Process for the Preparation of Cyclic Depsipeptides ONKURE, INC. (US) 2019-06-13 US disclosed
US-10100089-B2 Process for the preparation of cyclic depsipeptides ONKURE, INC. (US) 2018-10-16 US disclosed
US-20170183382-A1 Process for the Preparation of Cyclic Depsipeptides ONKURE, INC. (US) 2017-06-29 US disclosed
EP-3148540-A1 PROCESS FOR THE PREPARATION OF CYCLIC DEPSIPEPTIDES Onkure, Inc. (US) 2017-04-05 EP disclosed
WO-2015183897-A1 PROCESS FOR THE PREPARATION OF CYCLIC DEPSIPEPTIDES ONKURE, INC. (US) 2015-12-03 WO disclosed
US-4257947-A INTERMEDIATES FOR ANTIBACTERIAL CEPHALOSPORINS SMITHKLINE CORPORATION (US) 1981-03-24 US disclosed
US-4166816-A CYCLIZATION SMITHKLINE CORPORATION (US) 1979-09-04 US disclosed
US-4103086-A 8-Oxo-4-thia-1-azabicyclo (4.2.0)-oct-2-ene derivatives SMITHKLINE CORPORATION (US) 1978-07-25 US disclosed
US-4072674-A FOR CEPHALOSPORIN CONGENERS SMITHKLINE CORPORATION (US) 1978-02-07 US disclosed